Atlas Trials

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Clinical trial NCT03828019 · COMPLETED

Trial details

NCT number
NCT03828019
Sponsor
JHSPH Center for Clinical Trials
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Uveitis
Start date
2019-09-16
Primary completion
2024-04-02
Enrollment
227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.